Interaction between valproate and meropenem: a retrospective study.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 17609232)

Published in Ann Pharmacother on July 03, 2007

Authors

Isabel Spriet1, Jo Goyens, Wouter Meersseman, Alexander Wilmer, Ludo Willems, Wim Van Paesschen

Author Affiliations

1: University Hospital Gasthuisberg, Leuven, Belgium. Isabel.Spriet@uz.kuleuven.be

Articles by these authors

Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37

Early versus late parenteral nutrition in critically ill adults. N Engl J Med (2011) 12.10

Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med (2006) 7.26

Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med (2005) 4.61

Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med (2007) 4.40

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis (2005) 3.96

Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes (2006) 3.56

Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med (2004) 3.42

Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis (2009) 3.33

Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm (2008) 3.11

Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut (2010) 2.91

Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med (2014) 2.68

Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med (2004) 2.56

Status gelasticus after temporal lobectomy: ictal FDG-PET findings and the question of dual pathology involving hypothalamic hamartomas. Epilepsia (2005) 2.43

Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med (2007) 2.41

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med (2012) 2.39

Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med (2006) 2.22

Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med (2012) 2.14

Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med (2009) 2.10

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08

Guidelines recommendations on care of adult patients receiving home parenteral nutrition: a systematic review of global practices. Clin Nutr (2012) 2.08

A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med (2012) 2.06

Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab (2009) 1.84

Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis (2007) 1.83

Clinical review: What is the role for autopsy in the ICU? Crit Care (2010) 1.79

Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department. Qual Saf Health Care (2010) 1.77

Long-term outcome of transcatheter embolotherapy for acute lower gastrointestinal hemorrhage. Am J Gastroenterol (2009) 1.69

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. J Neurol Neurosurg Psychiatry (2012) 1.68

Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol (2008) 1.67

Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet (2013) 1.59

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer (2009) 1.56

Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy. Exp Neurol (2009) 1.52

Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med (2004) 1.50

Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med (2008) 1.49

Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41

Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge. Hepatology (2014) 1.40

Canonical correlation analysis applied to remove muscle artifacts from the electroencephalogram. IEEE Trans Biomed Eng (2006) 1.37

Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: a post hoc analysis. Am J Respir Crit Care Med (2012) 1.34

Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol (2009) 1.27

Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET. Neuroimage (2004) 1.21

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care (2006) 1.21

Neuronuclear assessment of patients with epilepsy. Semin Nucl Med (2008) 1.17

Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis. Antimicrob Agents Chemother (2013) 1.16

Defective membrane expression of the Na(+)-HCO(3)(-) cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci U S A (2010) 1.14

Anatomical-based FDG-PET reconstruction for the detection of hypo-metabolic regions in epilepsy. IEEE Trans Med Imaging (2004) 1.13

MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int (2007) 1.13

Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg Infect Dis (2010) 1.13

Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol (2011) 1.13

Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care (2003) 1.11

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother (2009) 1.08

Pathophysiology of renal hemodynamics and renal cortical microcirculation in a porcine model of elevated intra-abdominal pressure. J Trauma (2009) 1.07

Portal hypertension: from pathophysiology to clinical practice. Liver Int (2005) 1.05

Urea-splitting urinary tract infection contributing to hyperammonemic encephalopathy. Nat Clin Pract Urol (2007) 1.04

Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU. Intensive Care Med (2009) 1.03

The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab (2009) 1.02

Epidemiology of catheter-related infections in adult patients receiving home parenteral nutrition: a systematic review. Clin Nutr (2012) 1.02

Autoimmune-mediated encephalitis. Neuroradiology (2011) 1.01

Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology (2011) 1.01

Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial. Epilepsia (2013) 1.00

Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone. Epilepsia (2006) 1.00

A simple tool to improve medication reconciliation at the emergency department. Eur J Intern Med (2011) 1.00

Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol (2004) 1.00

Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy (2008) 0.99

Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia (2007) 0.99

Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs (2006) 0.99

Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J Clin Microbiol (2012) 0.98

A 59-year-old man with shock, polycythemia, and an underlying paraproteinemia. Chest (2007) 0.98

Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. Int J Cardiol (2012) 0.97

Invasive aspergillosis in the ICU: an emerging disease. Intensive Care Med (2007) 0.97

Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. J Med Microbiol (2005) 0.97

Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial. Trials (2011) 0.95

Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J Clin Microbiol (2011) 0.93

Needs and feelings of anxiety of relatives of patients hospitalized in intensive care units: implications for social work. Soc Work Health Care (2002) 0.93

Monoclonal gammopathy of undetermined significance: significant beyond hematology. Mayo Clin Proc (2009) 0.92

Augmented renal clearance in the critically ill: how to assess kidney function. Ann Pharmacother (2012) 0.92

Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure. Blood Purif (2005) 0.92

The impact of a transjugular intrahepatic portosystemic shunt on the pharmacokinetics of caspofungin in a critically ill patient. Pharmacology (2012) 0.92

The polycompartment syndrome: towards an understanding of the interactions between different compartments! Intensive Care Med (2007) 0.89

A new muscle artifact removal technique to improve the interpretation of the ictal scalp electroencephalogram. Conf Proc IEEE Eng Med Biol Soc (2005) 0.89

Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial. Crit Care (2012) 0.89

Improving the interpretation of ictal scalp EEG: BSS-CCA algorithm for muscle artifact removal. Epilepsia (2007) 0.88

Evaluation of drotrecogin alpha use in a Belgian university hospital. Pharm World Sci (2006) 0.87

Supplemental parenteral nutrition in critically ill patients. Lancet (2013) 0.87

A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System. Crit Care (2012) 0.86

Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters. Blood Purif (2003) 0.86

Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clin Infect Dis (2010) 0.86

In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. Brain (2011) 0.86

Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. J Antimicrob Chemother (2009) 0.84

Paroxysmal nonkinesigenic dyskinesias due to recurrent hypoglycemia caused by an insulinoma. Mov Disord (2009) 0.84